Totally agree with you but look at NYR that went up 4 folds, yes lower MC on Phase 1 mice
We have a viable product currently OTC at most pharmaceutical branches and were under 20MC.
Were talking 15M in bank i cant see them running out in a month
Ann: Travelan to progress to Phase 3 Clinical Trials in the US, page-49
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.0¢ |
Change
-0.003(3.23%) |
Mkt cap ! $20.52M | |||
| Open | High | Low | Value | Volume |
| 9.3¢ | 9.3¢ | 9.0¢ | $13.37K | 147.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6000 | 8.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.7¢ | 9000 | 1 |
View Market Depth
| Last trade - 15.40pm 23/05/2024 (20 minute delay) ? |
|
|||||
|
Last
9.0¢ |
Change
-0.003 ( 4.26 %) |
||||
| Open | High | Low | Volume | ||
| 9.2¢ | 9.2¢ | 9.0¢ | 87361 | ||
| Last updated 15.40pm 23/05/2024 ? | |||||
| IMC (ASX) Chart |